Skip To Main Content
Marten Trendelenburg on Muck Rack

Marten Trendelenburg

As seen in: Frontiers in Immunology, Arthritis Research & Therapy
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Marten Trendelenburg’s profile

Articles by Marten Trendelenburg

A case report of influenza-triggered RANBP2-associated acute necrotizing encephalomyelitis in an adult successfully treated with tocilizumab

|
By Marie-Anne Heusler, Sofia Sandgren, Jens Kuhle, Stephan Rüegg, Özgür Yaldizli, Cristina Granziera, Marten Trendelenburg, Severin Bausch
| Frontiers in Immunology
Abstract Here, we report a rare case of a 32-year-old patient presenting with a second episode of influenza A-triggered acute necrotizing encephalomyelitis (ANE) in the context of a Ran-binding protein 2 (RANBP2) -mutation, which was diagnosed after a previous influenza-triggered ANE at the age of eleven. Despite early treatment with corticosteroids, plasmapheresis and intravenous immunoglobulins (IVIG) no meaningful clinical improvement was observed during the first 6 weeks of treatment.
Open in Who Shared Issue with article?

Complement C1q promotes primary haemostasis in a microfluidic bleeding model

|
By Elaissa T. Hardy, Yumiko Sakurai, Wilbur Lam, Marten Trendelenburg, Peymane Zahiroddini
| Frontiers in Immunology
Abstract Background: In systemic inflammatory diseases, thrombotic complications often cannot be fully explained by traditional risk factors, suggesting that the immune system directly affects hemostasis. The complement system, particularly C1q (the recognition molecule of the classical complement pathway), has been shown to enhance primary hemostasis in vivo and to bind von Willebrand factor (vWF) in vitro. Aim: To investigate the role of the C1q-vWF interaction in human primary hemostasis.
Open in Who Shared Issue with article?

Role of lectin pathway complement proteins and genetic variants in organ damage and disease severity of systemic sclerosis: a cross-sectional study

|
By Michael Osthoff, Veronika K. Jaeger, Suzana Jordan, Marten Trendelenburg
| Arthritis Research & Therapy Verified
Arthritis Research & Therapy201921:76 https://doi.org/10.1186/s13075-019-1859-1 ©  The Author(s). 2019 Received: 28 November 2018 Accepted: 5 March 2019 Published: 18 March 2019 Abstract Background The role of the complement system in the pathogenesis of systemic sclerosis (SSc) is controversial.
Open in Who Shared Issue with article?
Show More